These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 23632121)

  • 21. Evaluation of hs-CRP and sLOX-1 Levels in Moderate-to-High Risk Acute Coronary Syndromes.
    Çoner A; Aydınalp A; Müderrisoğlu H
    Endocr Metab Immune Disord Drug Targets; 2020; 20(1):96-103. PubMed ID: 30961517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary CT angiographic characteristics of culprit lesions in acute coronary syndromes not related to plaque rupture as defined by optical coherence tomography and angioscopy.
    Ozaki Y; Okumura M; Ismail TF; Motoyama S; Naruse H; Hattori K; Kawai H; Sarai M; Takagi Y; Ishii J; Anno H; Virmani R; Serruys PW; Narula J
    Eur Heart J; 2011 Nov; 32(22):2814-23. PubMed ID: 21719455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome.
    Zhang YC; Wei JJ; Wang F; Chen MT; Zhang MZ
    Cell Biochem Biophys; 2012 Mar; 62(2):365-72. PubMed ID: 21947962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of noninvasive assessment of thin-cap fibroatheroma by multidetector computed tomography.
    Kashiwagi M; Tanaka A; Kitabata H; Tsujioka H; Kataiwa H; Komukai K; Tanimoto T; Takemoto K; Takarada S; Kubo T; Hirata K; Nakamura N; Mizukoshi M; Imanishi T; Akasaka T
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1412-9. PubMed ID: 20083077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidized low-density lipoprotein and C-reactive protein have combined utility for better predicting prognosis after acute coronary syndrome.
    Zhang YC; Tang Y; Chen Y; Huang XH; Zhang M; Chen J; Sun YG; Li YG
    Cell Biochem Biophys; 2014 Mar; 68(2):379-85. PubMed ID: 23943054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome.
    Kitamura M; Hata N; Takayama T; Hirayama A; Ogawa M; Yamashina A; Mera H; Yoshino H; Nakamura F; Seino Y
    Heart Vessels; 2016 Jun; 31(6):907-17. PubMed ID: 26081026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optical coherence tomography assessment of the spatial distribution of culprit ruptured plaques and thin-cap fibroatheromas in acute coronary syndrome.
    Toutouzas K; Karanasos A; Riga M; Tsiamis E; Synetos A; Michelongona A; Papanikolaou A; Triantafyllou G; Tsioufis C; Stefanadis C
    EuroIntervention; 2012 Aug; 8(4):477-85. PubMed ID: 22917732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma Pentraxin3 Level Is Associated With Plaque Vulnerability Assessed by Optical Coherence Tomography in Patients With Coronary Artery Disease.
    Tazaki R; Tanigawa J; Fujisaka T; Shibata K; Takeda Y; Ishihara T; Hoshiga M; Hanafusa T; Ishizaka N
    Int Heart J; 2016; 57(1):18-24. PubMed ID: 26673442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OX40 ligand levels and high-sensitivity C-reactive protein levels in blood from local coronary plaque and the femoral artery in patients with acute coronary syndrome or stable angina.
    Shi JZ; Wang LY; Zhu Y; Zhao CY; Liu W; Jiang SL; You HW; Wang Y; Xu FY; Tang YS; Cui LQ
    J Int Med Res; 2011; 39(4):1275-83. PubMed ID: 21986129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship among soluble CD105, hypersensitive C-reactive protein and coronary plaque morphology: an intravascular ultrasound study.
    Cui S; Lü SZ; Chen YD; He GX; Meng LJ; Liu JP; Song ZY; Liu XL; Song XT; Ge CJ; Liu H
    Chin Med J (Engl); 2008 Jan; 121(2):128-32. PubMed ID: 18272038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic performance of kinetic changes of high-sensitivity troponin T in acute coronary syndrome and in patients with increased troponin without acute coronary syndrome.
    Mueller M; Biener M; Vafaie M; Blankenberg S; White HD; Katus HA; Giannitsis E
    Int J Cardiol; 2014 Jul; 174(3):524-9. PubMed ID: 24814895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix Metalloproteinase-9 as a Marker for Plaque Rupture and a Predictor of Adverse Clinical Outcome in Patients with Acute Coronary Syndrome: An Optical Coherence Tomography Study.
    Kobayashi N; Takano M; Hata N; Kume N; Tsurumi M; Shirakabe A; Okazaki H; Shibuya J; Shiomura R; Nishigoori S; Seino Y; Shimizu W
    Cardiology; 2016; 135(1):56-65. PubMed ID: 27271099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAMTS4 level in patients with stable coronary artery disease and acute coronary syndromes.
    Zha Y; Chen Y; Xu F; Li T; Zhao C; Cui L
    Biomed Pharmacother; 2010 Mar; 64(3):160-4. PubMed ID: 19944557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optical coherence tomography derived differences of plaque characteristics in coronary culprit lesions between type 2 diabetic patients with and without acute coronary syndrome.
    Reith S; Battermann S; Hoffmann R; Marx N; Burgmaier M
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):700-7. PubMed ID: 24155115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical value of plasma pentraxin 3 levels for predicting cardiac troponin elevation after percutaneous coronary intervention.
    Wang Z; Sato A; Akiyama D; Kimura T; Tajiri K; Hoshi T; Sakai S; Koike A; Miyauchi T; Aonuma K
    Life Sci; 2014 Jan; 95(1):40-4. PubMed ID: 24333560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical utility of quantitative bright spots analysis in patients with acute coronary syndrome: an optical coherence tomography study.
    Minami Y; Phipps JE; Hoyt T; Milner TE; Ong DS; Soeda T; Vergallo R; Feldman MD; Jang IK
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1479-87. PubMed ID: 26202158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
    Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
    Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Utility of Soluble Lectin Type Oxidized Low-Density Lipoprotein Receptor as a Biomarker for Myocardial Infarction and Stable Angina.
    Narsini R; Bhaskar V; Luqman H; O SS; Parupati SSR; B V RRA; Krishna Mohan I
    Cureus; 2023 Dec; 15(12):e50719. PubMed ID: 38234947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography.
    Jia H; Abtahian F; Aguirre AD; Lee S; Chia S; Lowe H; Kato K; Yonetsu T; Vergallo R; Hu S; Tian J; Lee H; Park SJ; Jang YS; Raffel OC; Mizuno K; Uemura S; Itoh T; Kakuta T; Choi SY; Dauerman HL; Prasad A; Toma C; McNulty I; Zhang S; Yu B; Fuster V; Narula J; Virmani R; Jang IK
    J Am Coll Cardiol; 2013 Nov; 62(19):1748-58. PubMed ID: 23810884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low eicosapentaenoic acid to arachidonic acid ratio is associated with thin-cap fibroatheroma determined by optical coherence tomography.
    Wakabayashi Y; Funayama H; Ugata Y; Taniguchi Y; Hoshino H; Ako J; Momomura S
    J Cardiol; 2015 Dec; 66(6):482-8. PubMed ID: 25805011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.